Surveillance for Barrett's oesophagus: Is there light at the end of the metaplastic tunnel?

Surgeon

Volumn 1, Issue 3, 2003, Pages 152-156

  Belo, A C ^a   Playford, R J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Oesophageal carcinoma; Screening; Surveillance

Indexed keywords

BARRETT ESOPHAGUS; CANCER SCREENING; COLUMNAR EPITHELIUM; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTESTINE METAPLASIA; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SQUAMOUS EPITHELIUM; SURGICAL PATIENT; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 0038546636     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(03)80095-1     Document Type: Review

References (32)

1. Barrett, NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950; 38: 175-82.
2. Allison, JR, Johnston, AS. The oesophagus linked with gastric mucous membrane. Thorax 1953; 8: 87-101.
3. Stein, HJ, Siewert, JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration and surgical management. Dysphagia 1993; 8: 276-88.
4. Cameron, AJ, Zinnmeister, AR, Ballard, DJ, Carey, JA. Prevalence of columnar lined Barrett's esophagus: comparison of population based clinical and autopsy findings. Gastroenterology 1990; 99: 918-22.
5. Johnston, MH, Hammond, AS, Laskin, W, Jones, DM. The prevalence and clinical characteristics of short segments of specialised intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1966; 91: 1507-11.
6. Bartlesman, JF, Hameeteman, W, Tytgat, GN. Barrett's oesophagus. Eur J Cancer Prev 1992; 1: 323-25.
7. Spechler, SJ, Goyal, RK. The columnar lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996; 110: 614-21.
8. Sampliner, RE and The Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 1998; 93: 1028-32.
9. Shaheen, NJ, Crosby, MA, Bozymski, EM, Sandler, RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-38.
10. Spechler, SJ. Barrett's esophagus: An overrated cancer risk factor: (Editorials) Gastroenterology 2000; 119: 587-89.
11. Jankowski, JA, Provencale, D, Moayyedi, P. Oesophageal adenocarcinoma arising from Barrett's metaplasia has regional variations worldwide. Gastroenterology 2002.
12. Lagergren, J, Bergstrom, R, Lindgren, A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med 1999; 40: 825-31.
13. van Sandick, JW, van Lauschott, JJ, Kuiken, BW, Tytgat, GN, Offerhaus, GJ, Obertop, H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216-22.
14. Iftikhar, SY, James, PD, Steele, RJC, Hardcastle, JD, Atkinson, M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-58.
15. Gray, MR, Donnelly, RJ, Kingsnorth, AN. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut 1993; 34: 727-31.
16. Menke-Pluymers, MB, Hop, WC, Dees, J, van Blankenstein, M, Tilanus, HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett's) esophagus. The Rotterdam Esophageal Tumour Study Group. Cancer 1993; 72: 1155-58.
17. Dent, J, Bremner, CG, Collen, MJ et al. Working Party report to the World Congress of Gastroenterology, Sydney 1990. Barrett's oesophagus J Gastroenterol Hepatol 1991; 6:1-22.
18. Wilson, JMG, Junger, G. Principles and practice of screening for disease. Geneva: World Health Organisation, 1968.
19. Buttar, NS, Wang, KK, Sebo, TJ et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2000; 120: 1630-39.
20. Schnell, TG, Sontag, SJ, Chejfec, G et al. Long-term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-1619.
21. Macdonald, CE, Wicks, AC, Playford, RJ. Final results from 10-year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321: 1252-55.
22. van der Burgh, A, Dees, J, Hop, WCJ, van Blankstein, M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 5-8.
23. Nilsson, J, Skobe, V, Johansson, J, Willen, R, Johnsson, F. Screening for oesophageal adenocarcinoma: an evaluation of a surveillance programme for columnar metaplasia of the oesophagus. Scand J Gastroenterology 2000; 35: 10-16.
24. Wright, TA, Gray, MR, Morris, AI, Gilmore, IT, Ellis, A, Smart, HL et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39: 574-79.
25. Jankowski, JA, Harrison, RF, Perry, I, Balkwill, F, Tselepis, C. Barrett's metaplasia. Lancet 2000; 356: 2079-85.
26. Sharma, P, Morales, TG, Bhattacharyga, A et al. Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol 1998; 93: 332-35.
27. Lambert, R. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1997; 11: 651-62.
28. Salo, JA, Salminen, JT, Kiviluoto, TA et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antire-flux surgery. Ann Surg 1998; 227: 40-44.
29. Rudolph, RE, Vaughan, TL, Storer, BE et al. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000; 132: 612-20.
30. Heading, RC. Barrett's oesophagus - Time for a reality check? Digest Liver Dis 2001; 33: 313-15.
31. van Lieshout, EM, Jansen, JB, Peters, WH. Biomarkers in Barrett's esophagus (review). Int J Oncol 1998; 13: 855-64.
32. Fitzgerald, RC, Omary, MB, Triadafilopoulos, G. Acid modulation of HT-29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci 1997; 110: 663-71.